Curcumin mimics the neurocognitive and anti-inflammatory effects of caloric restriction in a mouse model of midlife obesity

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Sarker, Marjana Rahman ^a   Franks, Susan ^b   Sumien, Nathalie ^a   Thangthaeng, Nopporn ^a   Filipetto, Frank ^b   Forster, Michael ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of North Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CURCUMIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; INTERLEUKIN 6; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALORIC RESTRICTION; COGNITION; CONTROLLED STUDY; DISCRIMINATED ACTIVE AVOIDANCE; DISEASE MODEL; INTRAABDOMINAL FAT; MALE; MENTAL TASK; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OBESITY; PERCEPTIVE DISCRIMINATION; REDOX STRESS; SPATIAL LEARNING; SPATIAL MEMORY; SUBCUTANEOUS FAT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION; ANIMAL; BLOOD; DRUG EFFECTS; HUMAN; INFLAMMATION; MAZE TEST; METABOLISM; PATHOLOGY;

ADIPOSITY; ANIMALS; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CALORIC RESTRICTION; CURCUMIN; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MAZE LEARNING; MICE; OBESITY;

EID: 84949008846     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140431     Document Type: Article

References (67)

1. Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov2006; 5(11):919-931. PMID: 17080028
2. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) 2013; 37(6):889-891.
3. Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 2010; v17 (3):190-197.
4. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther2008; 326(1):196-208. doi: 10.1124/jpet.108.137455 PMID: 18417733
5. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Bio-factors 2013; 39(1):2-13. doi: 10.1002/biof.1079 PMID: 23339055
6. Bradford P. Curcumin and Obesity. Biofactors2013; 39: 78-87. doi: 10.1002/biof.1074 PMID: 23339049
7. Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angio-genesis and obesity in C57/BL mice. J Nutr2009; 139 (5):919-925. doi: 10.3945/jn.108.100966 PMID: 19297423
8. Strong R, Miller RA, Astle CM, Baur JA, de Cabo R, Fernandez E, et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2013 Jan; 68(1):6-16. doi: 10.1093/gerona/gls070 PMID: 22451473
9. Latham JR, Pathirathna S, Jagodic MM, Choe WJ, Levin ME, Nelson MT, et al. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 2009; 58:2656-2665. doi: 10. 2337/db08-1763 PMID: 19651818
10. Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev2006; 5:332-353. PMID: 16899414
11. Becskei C, Lutz TA, Riediger T. Blunted fasting-induced hypothalamic activation and refeeding hyper-phagiain late-onset obesity. Neuroendocrinology 2009; 90:371-382. doi: 10.1159/000251723 PMID: 19844081
12. Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, Hart RW Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 1999; 54: B492-B501. PMID: 10619312
13. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311:806-814. doi: 10.1001/jama.2014.732 PMID: 24570244
14. Anstey K, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a riskfactorfor dementia: a meta-analysis of prospective studies. Obes Rev 2011; 12(5):426-437.
15. Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Muñoz Sánchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 2015; 30:234-246. doi: 10.1002/gps.4245 PMID: 25504093
16. García-Ptacek S, Faxén-Irving G, Cermáková P, Eriksdotter M, Religa D. Body mass index in dementia. Eur J Clin Nutr2014; 68(11):1204-1209. doi: 10.1038/ejcn.2014.199 PMID: 25271014
17. Dubey A, Forster M, Lal H, Sohal R. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 1996; 333:189-197. PMID: 8806770
18. Spangler E, Long J, Bennett K, Marshall M, Minor R, deCabo R. Will Calorie restriction stave off age-related brain dysfunction, specifically to learning and memory? A review and critique of the rodent literature. In: Everitt A, Rattan S, Couteur D, de Cabo R, editors. Calorie restriction, Aging and Longevity London: Springer; 2010. p. 177-190.
19. Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011; 76(18):1568-1574. doi: 10.1212/WNL.0b013e3182190d09 PMID: 21536637
20. Gupta A, Mayer EA, Sanmiguel CP, Van Horn JD, Woodworth D, Ellingson BM, et al. Patterns of brain structural connectivity differentiate normal weight from overweight subjects. Neuroimage Clin 2015; 7:506-517. doi: 10.1016/j.nicl.2015.01.005 PMID: 25737959
21. Sweat V, Starr V, Bruehl H, Arentoft A, Tirsi A, Javier E, et al. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 2008; 31(3):198-207. doi: 10.1007/s10753-008-9065-3 PMID: 18347963
22. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006; 17:183-189. PMID: 16477259
23. Lekander M, von Essen J, Schultzberg M, Andreasson AN, Garlind A, Hansson LO, et al. Cytokines and memory across the mature life span of women. Scand J Psychol 2011; 52:229-235. doi: 10.1111/j.1467-9450.2010.00865.x PMID: 21332483
24. Arfanakis K, Fleischman DA, Grisot G, Barth CM, Varentsova A, Morris MC, et al. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One2013; 8 (8).
25. Guerreiro RJ, Santana I, Brás JM, Santiago B, Paiva A, Oliveira C. Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment. Neurodegener Dis 2007; 4 (6):406-412. PMID: 17934323
26. Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl) 2013; 91:323-328.
27. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010; 467:972-976. doi: 10. 1038/nature09421 PMID: 20927103
28. Chaudhari N, Talwar P, Parimisetty A, Lefebvred C, Ravanan P. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci2014; 8:213. doi: 10.3389/fncel. 2014.00213 PMID: 25120434
29. Bermejo P, Martín-Aragón S, Benedí J, Susín C, Felici E, Gil P, et al. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease fromMild Cognitive Impairment. Free Radic Res 2008; 42:162-170. doi: 10.1080/10715760701861373 PMID: 18297609
30. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011; 26:59-68. doi: 10.3233/JAD-2011-110284 PMID: 21593563
31. Dixit S, Bernardo A, Walker JM, Kennard JA, Kim GY, Kessler ES, et al. Vitamin C Deficiency in the Brain Impairs Cognition, Increases Amyloid Accumulation and Deposition, and Oxidative Stress in APP/PSEN1 and Normally Aging Mice. ACSChem Neurosci 2015.
32. Mazzetti AP, Fiorile MC, Primavera A, Lo Bello M. Glutathione transferases and neurodegenerative diseases. Neurochem Int 2015; 82C:10-18.
33. Chaudhari K, Wong MJ, Vann HP, Sumien N. Exercise training and antioxidant supplementation independently improve cognitive function in adult male and female GFAP-APOE mice. J Sport Health Sci 2014; 3:196-205.
34. de Fiebre NC, Sumien N, Forster MJ, de Fiebre CM. Spatial learning and psychomotor performance of C57BL/6 mice: age sensitivity and reliability of individual differences. Age 2006; 28(3):235. doi: 10.1007/s11357-006-9027-3 PMID: 22253492
35. Sumien N, Sims MN, Taylor HJ, Forster MJ. Profiling psychomotor and cognitive aging in four-way cross mice. Age (Dodr) 2006; 28(3):265-282.
36. McDonald SR, Sohal RS, Forster MJ. Concurrent administration of coenzyme Q10 and alpha-tocoph-erol improves learning in aged mice. Free Radic Biol Med 2005; 38(6):729-736. PMID: 15721983
37. Thangthaeng N, Sumien N, Forster MJ. Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain. Exp Gerontol 2008; 43:1077-1085. doi: 10.1016/j.exger.2008.08.045 PMID: 18783731
38. Sohal RS, Forster MJ. Caloric restriction and the aging process: a critique. Free Radic Biol Med 2014; 73:366-382. doi: 10.1016/j.freeradbiomed.2014.05.015 PMID: 24941891
39. Rebrin I, Forster MJ, Sohal RS. Association between life-span extension by caloric restriction and thiol redox state in two different strains of mice. Free Radic Biol Med 2011; 51:225-233. doi: 10.1016/j. freeradbiomed.2011.04.006 PMID: 21530646
40. Pires RC, Souza EE, Vanzela EC, Ribeiro RA, Silva-Santos JC, Carneiro EM, et al. Short-term calorie restriction improves glucose homeostasis in old rats: involvement of AMPK. Appl Physiol Nutr Metab 2014; 39:895-901. doi: 10.1139/apnm-2013-0520 PMID: 24844367
41. Harvie M, Pegington M, Mattson M, Frystyk J, Dillon B, Evans G, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease riskmarkers: a randomized trial in young overweight women. Int J Obes (Lond) 2011; 35:714-727.
42. Forster MJ, Sohal BH, Sohal RS. Reversible effects of long-term caloric restriction on protein oxidative damage. J Gerontol A Biol Sci Med Sci 2000; 55:B522-B529. PMID: 11078084
43. Forster M, Lal H. Estimating age-related changes in psychomotor function: influence of practice and of level of caloric intake in different genotypes. Neurobiol Aging 1999; 20:167-176. PMID: 10537026
44. Spindler SR. Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev 2005; 126:960-966. PMID: 15927235
45. Burke LE, Steenkiste A, Music E, Styn MA. A descriptive study of past experiences with weight-loss treatment. J Am Diet Assoc 2008; 180:640-647.
46. Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Caloric restriction mimetics: towards a molecular definition. Nat Rev Drug Discov2014; 13(10):727-740. doi: 10.1038/nrd4391 PMID: 25212602
47. Pu Y, Zhang H, Wang P, Zhao Y, Li Q, Wei X, et al. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncouplingprotein 2 pathway. Cell Physiol Biochem 2013; 32:1167-1177. doi: 10.1159/000354516 PMID: 24335167
48. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014; 25:1-18. doi: 10.1016/j.jnutbio.2013.09.001 PMID: 24314860
49. Kim T, Davis J, Zhang AJ, He X, Mathews ST. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009; 388(2):377-382. doi: 10.1016/j.bbrc.2009.08.018 PMID: 19665995
50. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004; 279:48487-48490. PMID: 15337754
51. Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 2014; 1842:446-462. doi: 10.1016/j.bbadis. 2013.05.017 PMID: 23707515
52. Banerjee M, Tripathi L, Srivastava V, Puri A, Shukla R. Modulation of inflammatory mediators by ibupro-fen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003; 25:213-224. PMID: 12784914
53. Wang J, Vanegas S, Du X, Noble T, Zingg J, Meydani M, et al. Caloric restriction favorably impacts metabolic and immune/inflammatory profiles in obese mice but curcumin/piperine consumption adds no further benefit. Nutr Metab (Lond) 2013; 10.
54. Shen LR, Xiao F, Yuan P, Chen Y, Gao QK, Parnell LD, et al. Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordr)2013; 35:1133-1142.
55. Gupta S, Kumar B, Nag T, Agrawal S, Agrawal R, Agrawal P, et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011; 27:123-130. doi: 10.1089/jop.2010.0123 PMID: 21314438
56. Taylor AW, Ku NO, Mortensen RF. Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. J Immunol 1990; 145:2507-2513. PMID: 2170518
57. Cohen AN, Veena MS, Srivatsan ES, Wang MB. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Arch Otolaryngol Head Neck Surg 2009; 135:190-197. doi: 10.1001/archotol.135.2.190 PMID: 19221248
58. Calabró P, Willerson J, Yeh E. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108:1930-1932. PMID: 14530191
59. Trujillo J, Granados-Castro LF, Zazueta C, Andérica-Romero AC, Chirino YI, Pedraza-Chaverrí J. Mitochondria as a target in the therapeutic properties of curcumin. Arch Pharm (Weinheim) 2014; 347:873-884.
60. Tang Y, Chen A. Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. Lab Invest 2014; 94:503-516. doi: 10.1038/labinvest.2014.42 PMID: 24614199
61. Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D.The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr Opin Clin Nutr Metab Care 2011; 14:41-48. doi: 10. 1097/MCO.0b013e32834136f2 PMID: 21102319
62. Priyadarsini KI. Chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des2013; 19:2093-2100. PMID: 23116315
63. Priyadarsini KI, Maity DK, Naik GH, Kumar MS, Unnikrishnan MK, Satav JG, et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med 2003; 35:475-484. PMID: 12927597
64. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, La Violette PS, Vitolo OV, et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010; 12:27-43. doi: 10.1007/s12017-009-8109-7 PMID: 20069392
65. Zheng D, Dong X, Sun H, Xu Y, Ma Y, Wang X. The overall impairment of core executive function components in patients with amnestic mild cognitive impairment: a cross-sectional study. BMC Neurol 2012; 12:138. doi: 10.1186/1471-2377-12-138 PMID: 23164134
66. Buckner R. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004; 44:195-208. PMID: 15450170
67. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-661. PMID: 17942826